PINX: CUBT
Morningstar‘s Stock Analysis CUBT
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile CUBT
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Curative Biotechnology Inc
PINX: CUBT
| Generation Bio Co Ordinary Shares
XNAS: GBIO
| RAPT Therapeutics Inc Ordinary Shares
XNAS: RAPT
| Immunovant Inc
XNAS: IMVT
| |
Price
| 0.01 | 3.79 | 16.62 | 38.39 |
Currency
| USD | USD | USD | USD |
Change
| $0.00 (7.48%) | +$0.02 (0.53%) | +$0.28 (1.71%) | −$1.40 (3.52%) |
Market Cap
| 6.19 Mil | 249.87 Mil | 571.03 Mil | 5.02 Bil |
Industry
| Biotechnology | Biotechnology | Biotechnology | Biotechnology |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Curative Biotechnology Inc Stock
No. CUBT does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
CUBT’s market cap is 6.19 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
CUBT’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare CUBT’s historical performance against its industry peers and the overall market.